These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19293285)

  • 1. Tense prescriptions? Alzheimer medications and the anthropology of uncertainty.
    Leibing A
    Transcult Psychiatry; 2009 Mar; 46(1):180-206. PubMed ID: 19293285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition-enhancing drugs in dementia: a guide to the near future.
    van Reekum R; Black SE; Conn D; Clarke D
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():35S-50S. PubMed ID: 9220128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of treatment with acetyl-cholinesterase inhibitors on psychopathological symptoms in Alzheimer's disease].
    Rösler M; Frey U
    Fortschr Neurol Psychiatr; 2002 Feb; 70(2):78-83. PubMed ID: 11823923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patient-relevant end points in Alzheimer's disease].
    Frölich L
    Dtsch Med Wochenschr; 2006 May; 131(19 Suppl 1):S31-4. PubMed ID: 16688663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment in severe dementia].
    Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer].
    Fuchsberger T; Padberg F; Faltraco F; Möller HJ; Hampel H
    MMW Fortschr Med; 2002 May; 144(20):36-9. PubMed ID: 12119881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.
    Frolich L
    J Nutr Health Aging; 2007; 11(4):357-8. PubMed ID: 17653499
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
    Smith B; Chur-Hansen A; Neale A; Symon J
    Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical treatment of Alzheimer's disease].
    Andersen SE
    Ugeskr Laeger; 2006 Oct; 168(44):3833; author reply 3833. PubMed ID: 17131519
    [No Abstract]   [Full Text] [Related]  

  • 19. Current issues in dementia pharmacotherapy.
    Daiello LA
    Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.